Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26210276 | 1.00 | USP2 (0.52) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL1709058 | 0.97 | USP2 (0.54) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL13398700 | 0.88 | USP2 (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Alcohol SCHEMBL2553945 | 0.87 | USP2 (0.58) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propane SCHEMBL5154976 | 0.87 | USP2 (0.58) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL20438581 | 0.87 | USP2 (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL25238278 | 0.87 | LMNA (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL325805 | 0.87 | KDM4E (0.52) | USP2KDM4EHSD17B10TSHRHTT | |
| SCHEMBL10329835 | 0.87 | LMNA (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL22279336 | 0.87 | LMNA (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017024016-A1 | PERSONAL CARE COMPOSITIONS COMPRISING POLYMERS DERIVED FROM VINYL ALCOHOL ETHERS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2017-02-09 | — | — | WO | disclosed |
| US-9351918-B2 | Polyglycerol-azelaic acid polyesters for cosmetic applications | GIULIANI S.P.A. (IT) | 2016-05-31 | — | — | US | disclosed |
| US-20150196480-A1 | POLYGLYCEROL-AZELAIC ACID POLYESTERS FOR COSMETIC APPLICATIONS | GUILIANI S.P.A. (IT) | 2015-07-16 | — | — | US | disclosed |
| US-8183315-B2 | Polymer composition | NOR-X-INDUSTRY AS (NO) | 2012-05-22 | — | — | US | disclosed |
| US-7824534-B2 | Copper electrolytic solution containing as additive compound having specific skeleton, and electrolytic copper foil manufactured therewith | NIPPON MINING & METALS CO., LTD. (JP) | 2010-11-02 | — | — | US | disclosed |
| US-20100224496-A1 | Copper electrolytic solution containing as additive compound having specific skeleton, and electrolytic copper foil manufactured therewith | NIPPON MINING & METALS CO., LTD. | 2010-09-09 | — | — | US | disclosed |
| US-20070290176-A1 | Polymer Composition | Funzionano AS (NO) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150196480-A1 | POLYGLYCEROL-AZELAIC ACID POLYESTERS FOR COSMETIC APPLICATIONS | DAGLA, GLA, MGLL | USP2 911/4885KDM4E 2840/4885LMNA 2919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.